Sun Pharma beats estimates; Q1 profit up by 31% to ₹1387 crore

Must Read

Sanju Samson to replace Shikhar Dhawan in T20 series against WI

Sanju Samson will replace injured Indian opener Shikhar Dhawan in the T20s series against West Indies starting from next...

Supreme Court lashes out on Centre & Delhi govts for Rising Pollution

The Apex Court of the Country, the Supreme Court on Monday lashed the Central and State Government for their...

Harbhajan Singh wishes BCCI Prez Sourav Ganguly to change Selection Panel

The Indian off-spinner Harbhajan Singh on Monday urged Sourav Ganguly, President of BCCI (The Board of Control for Cricket...

Sun Pharmaceuticals has said on tuesday that its Q1 net profit rose to 31.2 per cent year-on-year to ₹1387 crore in the June quarter from ₹1057 crore in the corresponding quarter last year.

Sun Pharmaceutical Industries Limited is an Indian multinational pharmaceutical company headquartered in Mumbai, Maharashtra that manufactures and sells pharmaceutical formulations and active pharmaceutical ingredients primarily in India and the United States.

It has said on tuesday that its Q1 net profit rose to 31.2 per cent year-on-year to ₹1387 crore in the June quarter from ₹1057 crore in the corresponding quarter last year.

The experts of an ET NOW poll survey had expected ₹994 crore profit for the quarter.

Higher profit came on the back of a forex gain of Rs 67 crore compared to a loss a year ago. Restructuring of domestic business had hurt the company’s bottom line in the quarter ended March.

Sun Pharma’s revenue increased 15.9 percent over the last year to Rs 8,374 crore in the April-June period—in line with the Rs 8,120-crore estimate.

Sun Pharma’s earnings before interest, tax, depreciation and amortisation rose 13.7 percent to Rs 1,696 crore. Its operating margin narrowed 50 basis points to 23 percent.

Shares of the drugmaker rose as much as 5.3 per cent to ₹444.5.The stock has risen 0.5 percent so far this year compared with a more than 10 percent fall in the benchmark NSE Nifty Pharma Index. Besides Divi’s Laboratories Ltd., Sun Pharma is the only stock that has gained in the index.This is even when the BSE sensex was down 600 points.

LEAVE A REPLY

Please enter your comment!
Please enter your name here

- Advertisement -

Latest News

SBI cuts one-year MCLR by 10 base points, home loans to get cheaper

After this cut, SBI's one-year MCLR comes down to 7.90% per annum from 8.00% per annum

A week after announcing all-in-one plans, Reliance Jio re-launches Rs 98 & Rs 149 prepaid plans

These two popular plans were pulled out by the company last week and a new all-in-one plan with hiked mobile tariffs and limited IUC minutes was announced.

‘Wonder Woman 1984’ trailer: Gal Gadot is back as the Amazonian princess

The official trailer of one of the most anticipated film, Wonder Woman 1984, dropped today which has several amazing action and fight sequences featuring...

Dhoni to produce show on personal lives of military officers

The popular Indian cricketer and former captain of Indian men’s national cricket team Mahendra Singh Dhoni is all set to produce a television show,...

Madhuri Dixit to make her Netflix debut in a Karan Johar production

After working on the big screen for several years, actor Madhuri Dixit is all set to make her debut in the digital world. And...
- Advertisement -

More Articles Like This